Author:
Kim Sun-Jin,Uehara Hisanori,Yazici Sertac,Busby Joseph Erik,Nakamura Toru,He Junqin,Maya Marva,Logothetis Christopher,Mathew Paul,Wang Xuemei,Do Kim-Anh,Fan Dominic,Fidler Isaiah J.
Publisher
Oxford University Press (OUP)
Reference63 articles.
1. Fidler IJ. Biology of cancer metastasis. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG (eds), Clinical Oncology, 3rd ed, pp. 59–79. Philadelphia (PA): Elsevier Science; 2004 .
2. Petrylak DP. Chemotherapy for advanced hormone refractory prostate cancer. Urology1999 ; 54 : 30 –5.
3. Beer T, Raghavan D. Chemotherapy for hormone refractory prostate cancer: beauty is in the eye of the beholder. Prostate2000 ; 45 : 183 –93.
4. van Brussel JP, Busstra MB, Lang MS, Catsburg T, Schroder FH, Mickisch GH. A phase II study of temozolomide in hormone-refractory prostate cancer. Cancer Chemother Pharmacol2000 ; 45 : 509 –12.
5. Petrylak DP, MacArthur RB, O'Connor J, Shelton G, Judge T, Balog J, et al. Phase I trial of Docetaxel with estramustine in androgen-independent prostate cancer. J Clin Oncol1999 ; 17 : 958 –67.
Cited by
87 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献